Valuation : Phosphagenics Limited

Market Cap 88.87M 63.64M 54.8M 51.45M 46.97M 88.23M 6.06B 610M 237M 3.07B 239M 234M 10.17B P/E 2024
-2.5x
P/E 2025 -6.43x
Enterprise Value 84.22M 60.31M 51.93M 48.76M 44.51M 83.62M 5.74B 578M 225M 2.91B 226M 222M 9.64B EV / Sales 2024
5.85x
EV / Sales 2025 23x
Free-Float
76.76%
Yield 2024 *
-
Yield 2025 -
Manager TitleAgeSince
Chief Executive Officer - 2020-04-30
Director of Finance/CFO 53 2018-12-27
Chief Operating Officer - 2020-04-30
Director TitleAgeSince
Director/Board Member - 2015-04-12
Chairman - 2018-12-31
Director/Board Member 59 2024-04-25
Change 5-day change 1-year change 3-year change Capi.($)
-14.29%-14.29% - - 63.76M
-1.52%-7.23%+57.90%+108.72% 1,047B
-0.82%-2.63%+50.05%+64.43% 646B
+0.37%-3.06%+21.87%+74.48% 451B
-1.64%-4.75%+35.59%+35.54% 355B
-0.39%-2.76%+21.39%+38.01% 291B
-1.19%-2.21%+1.53%+11.51% 252B
-0.59%-3.15%+49.83%+67.70% 234B
-1.05%-2.29%-19.91%-54.10% 203B
+0.45%-0.27%+29.84%+91.34% 181B
Average -2.07%-2.91%+27.56%+48.63% 406.59B
Weighted average by Cap. -0.88%-3.94%+36.91%+64.77%

Financials

2024 2025
Net sales 1.13M 811K 698K 656K 599K 1.12M 77.18M 7.77M 3.02M 39.14M 3.05M 2.98M 130M 1.24M 886K 763K 717K 654K 1.23M 84.35M 8.49M 3.3M 42.77M 3.33M 3.26M 142M
Net income -3.12M -2.24M -1.93M -1.81M -1.65M -3.1M -213M -21.42M -8.33M -108M -8.4M -8.21M -357M -4.42M -3.16M -2.72M -2.56M -2.33M -4.39M -301M -30.3M -11.79M -153M -11.88M -11.62M -505M
Net Debt -1.3M -930K -800K -751K -686K -1.29M -88.44M -8.9M -3.46M -44.85M -3.49M -3.41M -148M -4.65M -3.33M -2.87M -2.69M -2.46M -4.62M -317M -31.9M -12.41M -161M -12.5M -12.23M -532M
Logo Phosphagenics Limited
Avecho Biotechnology Limited is an Australia-based biopharmaceutical company. The Company develops and commercializes human and animal health products using its proprietary drug delivery system called Tocopheryl Phosphate Mixture (TPM). TPM is derived from Vitamin E using proprietary and patented processes. The Company's segments include Production and Human Health. The Production segment manufactures and sells TPM and Vital ET for use in drug delivery and cosmetic formulations. The Human Health portfolio covers delivery of pharmaceutical products through gels, injectables and patches, including conduct of research and development activities. The Company's products pipeline includes Weaner Pig Starter TPM Premix, Poultry TPM Premix, Dairy TPM Premix, Daptomycin, Propofol, Veterinary Applications, among others. Its TPM products are commercialized under license: Voveran TPM Gel, Instanac TPM Gel, Vital ET, and Ashland TPM.
Employees
-